TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Sigrid Therapeutics AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,115
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-27,996
|
-20,558
|
-14,622 |
| EBITDA |
-28,328
|
-20,776
|
-14,380 |
| Total assets |
22,997
|
49,322
|
36,761 |
| Current assets |
15,744
|
44,848
|
34,594 |
| Current liabilities |
9,043
|
6,504
|
3,066 |
| Equity capital |
13,954
|
42,818
|
33,695 |
| - share capital |
477
|
488
|
438 |
| Employees (average) |
7
|
7
|
9 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
60.7%
|
86.8%
|
91.7% |
| Turnover per employee |
159
|
0
|
0 |
| Profit as a percentage of turnover | -2510.9% | ||
| Return on assets (ROA) |
-121.7%
|
-41.7%
|
-39.8% |
| Current ratio |
174.1%
|
689.5%
|
1128.3% |
| Return on equity (ROE) |
-200.6%
|
-48.0%
|
-43.4% |
| Change turnover |
1,115
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
-2
|
2 |
| Chg. No. of employees % |
0%
|
-22%
|
29% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.